JOHNSON & JOHNSON·4

Feb 9, 7:40 PM ET

Wengel Kathryn E 4

4 · JOHNSON & JOHNSON · Filed Feb 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Johnson & Johnson (JNJ) EVP Kathryn Wengel Exercises Options

What Happened

  • Kathryn E. Wengel, EVP and Chief TO & Risk Officer at Johnson & Johnson, exercised stock options on 2026-02-06. She acquired 38,945 shares at an exercise price of $101.87 per share (total value $3,967,327). To cover the exercise price and tax obligations, 27,270 shares were withheld/sold at $239.99 per share (proceeds $6,544,527). The Form 4 shows the option exercise and the corresponding share withholding/disposition.

Key Details

  • Transaction date: 2026-02-06.
  • Option exercise: 38,945 shares @ $101.87 — reported value $3,967,327 (code M).
  • Withholding/disposition for taxes/exercise: 27,270 shares @ $239.99 — reported value $6,544,527 (code F).
  • Implied net shares retained from this transaction: 11,675 shares (38,945 acquired − 27,270 withheld), based on the reported entries; final beneficial ownership after the transaction is not provided in the excerpt.
  • Relevant footnotes:
    • F1: Options were auto‑exercised immediately prior to expiration.
    • F2: Shares were withheld to pay the exercise price and taxes.
    • F3/F4: References to shares held/accumulated in the J&J Savings Plan (as of 1/31/2026).
  • Filing: Report filed 2026-02-09 for a 2026-02-06 transaction — appears to be timely.

Context

  • This was an option exercise with shares withheld to cover costs (a common, routine corporate action often described as a cashless/net share settlement), not an open‑market purchase or discretionary sale that would necessarily signal personal market sentiment. The Form 4 records both the derivative exercise (M) and the withholding/disposition for taxes/exercise (F) so readers can see the gross exercise and the shares used to satisfy obligations.

Insider Transaction Report

Form 4
Period: 2026-02-06
Wengel Kathryn E
EVP, Chief TO and Risk Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-06$101.87/sh+38,945$3,967,327133,225.874 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-06$239.99/sh27,270$6,544,527105,955.874 total
  • Exercise/Conversion

    Employee Stock Options (Right to Buy)

    [F1]
    2026-02-06$101.87/sh38,945$3,967,3270 total
    Exercise: $101.87From: 2019-02-09Exp: 2026-02-08Common Stock (38,945 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: By ESOP)
    281
  • Common Stock

    [F4]
    (indirect: By 401(k))
    86
Footnotes (4)
  • [F1]Reflects the auto-exercise of options immediately prior to their expiration.
  • [F2]Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.
  • [F3]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
  • [F4]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
Signature
/s/ Joleen Morgan, as attorney-in-fact for Kathryn E. Wengel|2026-02-09

Documents

4 files
  • 4
    wk-form4_1770684007.xmlPrimary

    FORM 4

  • EX-24.1

    EX-24.1 WENGEL POA

  • GRAPHIC
    wengel-poasec161232025001.jpg
  • GRAPHIC
    wengel-poasec161232025002.jpg